A Case of Mycobacterium kansasii Lymphadenitis in HIV-infected Patient.
- Author:
Seon Young PARK
1
;
Ga Ram LEE
;
Ji Won MIN
;
Ja Young JUNG
;
Young Do JEON
;
Hyoung Shik SHIN
;
Bum Sik CHIN
Author Information
- Publication Type:Case Report
- Keywords: Mycobacterium kansasii; Lymphadenitis; Human immunodeficiency virus
- MeSH: Antiretroviral Therapy, Highly Active; Drainage; HIV; Humans; Immunocompromised Host; Immunosuppression; Korea; Lamivudine; Lung Diseases; Lymphadenitis; Mycobacterium; Mycobacterium kansasii; Nontuberculous Mycobacteria
- From:Infection and Chemotherapy 2012;44(6):526-529
- CountryRepublic of Korea
- Language:Korean
- Abstract: Nontuberculous mycobacteria (NTM) are widely present in the environment, although they rarely cause infection in humans. However, infection by NTM has been increasingly recognized worldwide in the context of the human immunodeficiency virus (HIV) epidemic and therapeutic immunosuppression. Mycobacterium kansasii is a slow-growing photochromogenic mycobacterium, which mainly causes pulmonary infection in patients with predisposing lung diseases, and, occasionally, disseminated infection with poor outcomes in immunocompromised patients. We report on the first case of lymphadenitis caused by infection with M.kansasii in an HIV-infected patient in Korea. The patient showed significant improvement after receiving antituberculous therapy (isoniazid, rifabutin) in combination with surgical drainage and highly active antiretroviral therapy (abacavir, lamivudine, and lopinavir/ritonavir).
